LNP023
selective factor B serine protease inhibitor orally available, retinal barrier penetrant J. Med. Chem., Feb. 19, 2020 Novartis (NIBR), Cambridge, MA
Molecules of the Month - February 2020
Molecules of the Month
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- "compound 25"
- "compound 25"-2
- WF-47-JS03
- BMS-986260
- GNF2133